Revenue Growth (YoY)
Higher than 88% of Healthcare sector peers
Updated 1078h ago
Sector Performance
88th percentileEXAS
23.1%
Sector Median
6.2%
Sector Avg
3.8%
Deep Analysis
Exact Sciences Corporation (EXAS) has a Revenue Growth (YoY) of 23.1% as of May 2026.
This places EXAS in the 88th percentile of the Healthcare sector, which has a median Revenue Growth (YoY) of 6.2% and a sector average of 3.8%. EXAS's Revenue Growth (YoY) is 272.6% above the sector median, a significant divergence that warrants closer examination. In context: Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about EXAS?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
How does EXAS's Revenue Growth (YoY) compare to its sector?
EXAS's Revenue Growth (YoY) of 23.1% compares to a Healthcare sector median of 6.2%, placing it in the 88th percentile.
Who are EXAS's closest peers by Revenue Growth (YoY)?
The closest Healthcare peers by Revenue Growth (YoY) include: AMGN (5.8%), CPRX (5.6%), HIMS (3.8%), BAX (2.9%), BMY (2.6%).
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master EXAS's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EXAS research report →EXAS
23.1%
Sector Median
6.2%
Sector Avg
3.8%
How EXAS's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.